Related Experiment Video
Updated: Apr 25, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
[Functional diarrhea - pathophysiology, investigation and treatment]
1Abteilung für Gastroenterologie und Hepatologie, Universitätsspital Basel.
Diarrhea-predominant irritable bowel syndrome (IBS) causes chronic diarrhea and abdominal pain. Understanding its complex causes, like visceral hypersensitivity and gut motility issues, is key to effective, individualized treatment strategies.
Area of Science:
- Gastroenterology
- Functional Bowel Disorders
Context:
- Diarrhea-predominant irritable bowel syndrome (IBS) is a common cause of functional diarrhea.
- Characterized by chronic, intermittent diarrhea and abdominal pain.
Purpose:
- To provide an overview of the pathophysiology, diagnostic investigations, and treatment of IBS.
- To highlight the complexity of IBS etiology.
Summary:
- IBS pathophysiology involves visceral hypersensitivity, altered gut motility, and autonomic nervous system dysfunction.
- Genetic and psychosocial factors also contribute to IBS development.
- Treatment requires a personalized approach, integrating general measures, pharmacotherapy, diet, psychotherapy, and alternative therapies.
Impact:
- Improved understanding of IBS pathophysiology can lead to more targeted treatments.
- Personalized management strategies can enhance patient outcomes and quality of life.
- This overview serves as a guide for clinicians managing patients with functional diarrhea.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...

